← Back to screener

ASSEMBLY BIOSCIENCES, INC. ASMB

Rank #2455 · Nasdaq · $0.3B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
16.8
P/E
-8.0
P/B
7.78
ROE
-97.8%
Op. Margin
-159.3%
Debt Ratio
209%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -8.0x, P/B 7.78x. Ranks in the top 81% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -97.8%. Ranks in the top 92% of the universe.

Safety ★★☆☆☆
Weak

Debt ratio 209%. Ranks in the top 63% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★★
Excellent

Revenue growth of 298.2% year over year. Ranks in the top 1% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$-0.0B$-0.0B$-0.0B–-68
2012–$-0.0B$-0.0B$-0.0B–-57
2013–$-0.0B$-0.0B$-0.0B–-63
2014–$-0.0B$-0.0B$0.0B–15
2015–$-0.0B$-0.0B$0.0B–52
2016–$-0.0B$-0.0B$0.0B–61
2017–$-0.0B$-0.0B$0.1B–31
2018$0.0B$-0.0B$-0.0B$0.1B–47
2019$0.0B$-0.1B$-0.0B$0.1B-579.172
2020$0.0B$-0.1B$-0.1B$0.1B-626.459
2021$0.1B$-0.1B$-0.1B$0.3B-81.916
2022$0.0B$-0.1B$-0.1B$0.2B-2121.79
2023$0.0B$-0.1B$-0.1B$0.2B–11
2024$0.0B$-0.1B$-0.1B$0.1B-902.5116
2025$0.0B$-0.0B$-0.0B$0.0B-159.3209

← See the full screener